Targeting NFE2L2/GPX4 signaling pathway: Therapeutic potential of arsenic sulfide-induced ferroptosis in combating rhabdomyosarcoma

  • Int Immunopharmacol. 2024 Dec 25;143(Pt 3):113614. doi: 10.1016/j.intimp.2024.113614.
Yu Cai  1 ,  Shumin Lu  1 ,  Chuanying Zhu  1 ,  Ting Kang  1 ,  Zhiyi Liu  1 ,  Ruizhe Huang  1 ,  Yawei Zhao  1 ,  Siyu Chen  2
Affiliations
  • 1. Department of Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, PR China.
  • 2. Department of Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, PR China. Electronic address: [email protected].
PMID: 39547014 DOI: 10.1016/j.intimp.2024.113614
Products